Under its medium-term management plan, the Group positions M&A at the core of its growth strategy and resolved at the Board of Directors meeting on 2026-10-06 to acquire shares of Marin Profoods and make it a subsidiary. The acquisition price is 5,030 million yen for common shares, the number of shares to be acquired is 124,600 shares, and the scheduled transfer execution date is 2026-10-30. The impact on future consolidated results is under examination.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2929","jir_company_name":"Pharma Foods International Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-06","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/2929-20261006-01.pdf","jir_short_summary":"Under its medium-term management plan, the Group positions M&A at the core of its growth strategy and resolved at the Board of Directors meeting on 2026-10-06 to acquire shares of Marin Profoods and make it a subsidiary. The acquisition price is 5,030 million yen for common shares, the number of shares to be acquired is 124,600 shares, and the scheduled transfer execution date is 2026-10-30. The impact on future consolidated results is under examination.","jir_summary":"### Overview of the M&A\nThe Company, aiming to integrate \"pharmaceuticals\" and \"food,\" resolved as part of its medium-term management plan \"New Value Creation 1K Project\" to acquire shares of Marin Profoods and make it a subsidiary. Marin Profoods is engaged in planning, development, and sales of marine, soybean, and agricultural processed products, and seeks to expand primarily in the medical food market for hospitals and nursing care facilities. The number of shares to be acquired is 124,600 shares, the acquisition price is 5,030 million yen, and 100% ownership is planned.\n\n### Outlook and Impact\nThis transaction aims to expand into new business areas and sales channels and is expected to contribute to medium- to long-term corporate value enhancement. The scheduled transfer execution date is 2026-10-30, subject to review by the Japan Fair Trade Commission. The Company will examine the impact on consolidated results and disclose information as appropriate.","jir_financial_highlights":"Number of Shares to Be Acquired: 124,600 shares (Unknown)\nAcquisition Price: 5,030 million yen (Unknown)","jir_category":"","jir_hashtags":"#MarinProfoodsSubsidiarization, #M&AAlliance, #MediumTermManagementPlan","jir_key_figures":"Number of Shares to Be Acquired: 124,600 shares (voting rights etc.: 124,600)\nAcquisition Price: 5,030 million yen\nScheduled Transfer Execution Date: 2026-10-30","jir_meta_title":"Pharma Foods International Co., Ltd. Resolves to Make Marin Profoods a Subsidiary\uff5cOctober","jir_meta_description":"Pharma Foods International Co., Ltd. plans to acquire 100% of Marin Profoods. Number of shares to be acquired: 124,600 shares; acquisition price: 5,030 million yen. Impact on future consolidated results is undetermined.","jir_og_title":"Pharma Foods International Co., Ltd. to Make Marin Profoods a Subsidiary\uff5cOctober","jir_og_description":"Pharma Foods International Co., Ltd. has resolved to acquire shares of Marin Profoods and make it a subsidiary. Terms: 124,600 shares, 5,030 million yen. Execution planned following Japan Fair Trade Commission review.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":57923,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"corporate_restructuring","footnotes":""},"sector":[],"importance":[],"class_list":["post-127902","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n